Health Ministry proposes amendment to drug rules to bring antimicrobials under central oversight
New Delhi, Nov. 19 -- The Union Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to include 'antimicrobials' in the definition of 'New Drug' under Rule 2(1)(w)(v).
The proposed amendment has been introduced through a draft Gazette Notification G.S.R. 983 (E) dated November 6.
Antimicrobial resistance (AMR) is a major global public health concern and a priority requiring coordinated action. The G20 New Delhi Leaders' Declaration also underscored the need to address antimicrobial resistance through a One Health approach.
The proposed amendment has been initiated in view of concerns regarding the grant of manufacturing licences for antimicrobial products without adequate reg...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.